Imatinib co-loaded targeted realgar nanocrystal for synergistic therapy of chronic myeloid leukemia

Advances in aggregatable nanoparticles for tumor-targeted drug delivery

(2020) Wenqi Yu et al.   CHINESE CHEMICAL LETTERS

Response and Resistance to BCR-ABL1-Targeted Therapies

(2020) Theodore P. Braun et al.   CANCER CELL

Cathepsin B-responsive nanodrug delivery systems for precise diagnosis and targeted therapy of malignant tumors

(2020) Yanan Li et al.   CHINESE CHEMICAL LETTERS

NIR-triggered drug delivery system based on phospholipid coated ordered mesoporous carbon for synergistic chemo-photothermal therapy of cancer cells

(2020) Anman Zhang et al.   CHINESE CHEMICAL LETTERS

Protein nanoparticles containing Cu(II) and DOX for efficient chemodynamic therapy via self-generation of H2O2

(2020) Rui Cao et al.   CHINESE CHEMICAL LETTERS

Graphene nanosheets damage the lysosomal and mitochondrial membranes and induce the apoptosis of RBL-2H3 cells

(2020) Ling Liu et al.   SCIENCE OF THE TOTAL ENVIRONMENT

The Role of Ligands in the Chemical Synthesis and Applications of Inorganic Nanoparticles

(2019) Amelie Heuer-Jungemann et al.   CHEMICAL REVIEWS

The Simpler the Better: Oral Arsenic for Acute Promyelocytic Leukemia

(2019) Hong-Hu Zhu et al.   BLOOD

One-pot photoreduction to prepare NIR-absorbing plasmonic gold nanoparticles tethered by amphiphilic polypeptide copolymer for synergistic photothermal-chemotherapy

(2018) Siqi Yang et al.   CHINESE CHEMICAL LETTERS

Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy

(2018) Simona Soverini et al.   Molecular Cancer

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

(2017) Andreas Hochhaus et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clearance Pathways and Tumor Targeting of Imaging Nanoparticles

(2015) Mengxiao Yu et al.   ACS Nano

Chronic myeloid leukaemia

(2015) Jane F Apperley   LANCET

Arsenic sulfide nanoparticles prepared by milling: properties, free-volume characterization, and anti-cancer effects

(2014) Zdenka Bujňáková et al.   JOURNAL OF MATERIALS SCIENCE

Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment

(2011) S. Chu et al.   BLOOD

Impact of albumin on drug delivery — New applications on the horizon

(2011) Bakheet Elsadek et al.   JOURNAL OF CONTROLLED RELEASE

Albumin-based nanoparticles as potential controlled release drug delivery systems

(2011) Ahmed O. Elzoghby et al.   JOURNAL OF CONTROLLED RELEASE

Curing CML with imatinib—a dream come true?

(2011) Michael Deininger   Nature Reviews Clinical Oncology

Properties of arsenic sulphide As4S4 nanoparticles prepared by high-energy milling

(2011) Peter Baláž et al.   POWDER TECHNOLOGY

Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein

(2010) P. Isakson et al.   BLOOD

As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia

(2010) J.-H. Mao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Arsenic in Cancer Treatment: Challenges for Application of Realgar Nanoparticles (A Minireview)

(2010) Peter Baláž et al.   Toxins

Fluorescent Nanogel of Arsenic Sulfide Nanoclusters

(2009) Junzhong Wang et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia

(2009) Q.-Y. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia

(2009) J. Hu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway

(2008) Valérie Lallemand-Breitenbach et al.   NATURE CELL BIOLOGY